# Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

> **NCT03405571** · — · UNKNOWN · sponsor: **University of Athens** · enrollment: 800 (estimated)

## Conditions studied

- Multiple Myeloma
- Venous Thromboembolism

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT03405571
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2021-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405571, "Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03405571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*